Sugi Predict

Sugi Predict / Compounds / SCHEMBL3317099

SCHEMBL3317099

SCHEMBL3317099

O=S(=O)(Oc1ccc2nc(Oc3ccccc3)ccc2c1)C(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 2/20 0.45
▸ CA2 P00918 2/20 0.45
▸ SCN9A Q15858 9/20 0.40
▸ PDE1A P54750 1/20 0.40
▸ PDE1B Q01064 1/20 0.40
▸ PDE4B Q07343 1/20 0.40
▸ PDE7A Q13946 1/20 0.40
▸ CA9 Q16790 1/20 0.39
▸ PLA2G10 O15496 1/20 0.38
▸ SCN7A Q01118 3/20 0.38
▸ KCNH2 Q12809 3/20 0.38
▸ MAP4K4 O95819 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HTT P42858 1/20 0.38
▸ HSD11B1 P28845 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ SCN5A Q14524 1/20 0.37
▸ PPARG P37231 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3320014 0.90 CA1 (0.43) CA1CA2SCN9APDE1APDE1B
SCHEMBL1064633 0.87 CA1 (0.50) CA1CA2SCN9APDE1APDE1B
SCHEMBL3316376 0.85 CA1 (0.40) CA1CA2SCN9APLA2G10ALDH1A1
SCHEMBL3320919 0.84 CA1 (0.41) CA1CA2SCN9APDE1APDE1B
SCHEMBL3317026 0.83 CA1 (0.47) CA1CA2SCN9ASCN7AKCNH2
SCHEMBL3316672 0.82 SMN1; SMN2 (0.43) CA1CA2SCN9APDE1APDE1B
SCHEMBL1713420 0.77 CA1 (0.61) CA1CA2CA9HTTHSD11B1
SCHEMBL29839512 0.77 CA1 (0.61) CA1CA2CA9HTTHSD11B1
SCHEMBL14349812 0.77 CA1 (0.49) CA1CA2SCN9ACA9SCN7A
SCHEMBL4056753 0.77 CA1 (0.51) CA1CA2CA9HTTHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7638630-B2 Very Late Antigen-4 dependent inflammatory disease; asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, inflammatory skin disorders, autoimmune disorders, or atherosclerosis, inflammatory skin disorder; methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate UCB PHARMA S.A. (BE) 2009-12-29 — — US claimed
US-20080064720-A1 2,6-Quinolinyl And 2,6-Naphthyl Derivatives, Processes For Preparing Them And Their Uses As Vla-4 Inhibitors UCB, S.A. (BE) 2008-03-13 — — US claimed
EP-1501801-B1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF VLA-4 DEPENDENT DISEASES UCB PHARMA SA (BE) 2008-01-23 — — EP claimed
EP-1870402-A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors UCB Pharma, S.A. (BE) 2007-12-26 — — EP claimed
EP-1501801-A1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS UCB, S.A. (BE) 2005-02-02 — — EP claimed
WO-2003093237-A1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS UCB, S.A. (BE) 2003-11-13 — — WO claimed
US-11038145-B2 Laminated film and process for manufacturing the same, as well as method for analyzing laminated film SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-06-15 — — US disclosed
WO-2020116367-A1 POLYBUTADIENE AND METHOD FOR PRODUCING SAME 宇部興産株式会社 2020-06-11 — — WO disclosed
US-20170288169-A1 LAMINATED FILM AND PROCESS FOR MANUFACTURING THE SAME, AS WELL AS METHOD FOR ANALYZING LAMINATED FILM SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-05 — — US disclosed
US-20170288170-A1 LAMINATED FILM AND PROCESS FOR MANUFACTURING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-05 — — US disclosed
US-9646940-B2 Gas barrier film and electronic device Konica Minolta, Inc. (JP) 2017-05-09 — — US disclosed
US-20160272883-A1 COATED SEMICONDUCTOR NANOPARTICLE AND METHOD FOR MANUFACTURING THE SAME Konica Minolta, Inc. (JP) 2016-09-22 — — US disclosed
EP-3070143-A1 COATED SEMICONDUCTOR NANOPARTICLE AND METHOD FOR MANUFACTURING THE SAME Konica Minolta, Inc. (JP) 2016-09-21 — — EP disclosed
US-6506537-B2 Photopolymerization JSR CORPORATION (JP) 2003-01-14 — — US disclosed
US-20020012872-A1 Radiation-sensitive resin composition JSR CORPORATION (JP) 2002-01-31 — — US disclosed
EP-1164433-A1 Radiation-sensitive resin composition JSR Corporation (JP) 2001-12-19 — — EP disclosed
US-6001165-A FOR INK JET PRINTERS WHICH ABSORBS INK RAPIDLY, DOES NOT BLOT, WATER RESISTANCE OJI-YUKA SYNTHETIC PAPER CO., LTD. (JP) 1999-12-14 — — US disclosed
EP-0887200-A1 Coating composition for recording material and process for producing recording material OJI-YUKA SYNTHETIC PAPER CO., LTD. (JP) 1998-12-30 — — EP disclosed
CN-1203250-A Coating composition for recording material and process for producing recording material OJI YUKA SYNT PAPER CO LTD (JP) 1998-12-30 — — CN disclosed
US-5622784-A WATERPROOFING; MODIFIED SILICON DIOXIDE THIN FILM SEIKO EPSON CORPORATION (JP) 1997-04-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064720-A1 2,6-Quinolinyl And 2,6-Naphthyl Derivatives, Processes For Preparing Them And Their Uses As Vla-4 Inhibitors VCAM1, HRH4, LTA4H CA1 4020/4885CA2 2862/4885SCN9A 460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.